All Industries

SYMBIOME LAUNCHES ITS PROPRIETARY POSTBIOMIC SKINCARE LINE ON DERMSTORE AND SKINSTORE, DISRUPTING TRADITIONAL BEAUTY CATEGORIES

Symbiome

Symbiome, the leading microbiome-nourishing skincare company, is now available for sale on Dermstore and SkinStore, The Hut Group's digital beauty retailers. Symbiome continues to scale its offerings from its direct-to-consumer platform, through online retailers and brick-and-mortar channels. Symbiome’s proprietary PostBiomic fermentation process takes place in Brazil, where the plants are fermented with microbes that are derived from the plant’s microbiome and native biome. The plants and their microbes co-evolved together over millions of years, allowing Symbiome’s PostBiomic fermentation process to optimize and unlock the maximum benefit and potency from these ancient biological relationships. The fermentation typically takes weeks but can take longer, depending on the product. The resulting products contain a complex and dense variety of bioactive molecules with optimal bioavailability, each intentionally crafted to nurture the microbiome the way nature intended. Symbiome’s Chief Operating Officer, said of the partnership: “[w]e couldn’t be more excited to launch on Dermstore and SkinStore. They are the premiere global spots to shop for prestige and scientifically efficacious skincare.” About Dermstore Founded in 1999, Dermstore.com has been considered the “Skincare Authority” by offering the highest quality products, straight-from-the-experts information, and fostering a passionate community dedicated to learning and exchanging information about healthy skin. About SkinStore Founded in 1997, SkinStore is the destination for beauty discovery: our unmatched range of premium beauty—from the best in proven, quality skin care to the most sought-after make-up and hair care brands—SkinStore is the go-to online retailer for the ultimate beauty routine. With over 350 of the world’s top brands, SkinStore invites its customers to explore beauty’s most innovative products across categories and trending ingredients. About Symbiome Symbiome is a San Francisco-based microbiome biotechnology company focusing on health and wellness. They are the developers of the Symbiome ® brand of BioIntact ® fermented skincare products that nourish and protect the skin and its microbiome, restoring what our skin has lost in the modern world. Symbiome has sponsored three international academic research expeditions deep into the Amazon rainforest, defining an evolutionary reference for the microbiome and transforming our understanding of the healthy human microbiome. Symbiome scientists have translated this groundbreaking research into a line of unique, proprietary skincare products formulated with naturally fermented, Amazonian botanicals. The brand's skincare lineup includes ten clean, organic, sustainable, and traceable products — each with less than eight ingredients. Learn more about Symbiome, and follow Symbiome on Instagram, LinkedIn and Facebook. Contact Details Ali Taekman ali@bpcm.com Company Website https://www.symbiome.com

September 22, 2023 12:00 PM Eastern Daylight Time

Image

MultiversX Rivals the World’s Largest Hackathon Prize Fund of $1M to Expand the Blockchain Ecosystem at xDay 2023

STORM Partners

Sep 22nd, 2023 - MultiversX has announced the launch of its global development event, the xDay Hackathon, to further expand the Web3 ecosystem for new and emerging projects. Organized alongside Encode and Dora Hacks, the event is powered by its esteemed partners, including Google Cloud, Tencent Cloud and Deutsche Telekom, offering prizes and funding of up to $1M. MultiversX is offering one of the largest hackathon prize funds in history. Beyond cash and seed funding rewards, the grand prize offers the winning project an exclusive spot on the xLaunchpad platform. This grants them access to an incubation platform that provides emerging projects with assistance in multiple areas including: funding, legal & compliance, marketing and developer support amongst other services, while also giving access to a community of over 100,000 users. The xDay Hackathon has already garnered impressive interest, with over 500 participants registered. The event has been designed to offer invaluable learning opportunities, including 19 workshops and 4 AMA sessions. Developers can build tools, scripts or smart contracts in languages like Rust, C/C++, Python, and TypeScript, making the xDay Hackathon a global call for coders of all skill levels. " The xDay Hackathon is the very best time to build. Builders, tools, prizes, funding. Everything is ready for the global builder community. Time for builders to explore new ways of utilizing the unique capabilities of the MultiversX network. " says Beniamin Mincu, CEO of MultiversX. Registrations for the xDay Hackathon are still open at xday.com/hackathon until October 16th. The event spans across six tracks: AI, DeFi, Payments, Infrastructure & Dev Tooling, Mobile Apps, Gaming & Metaverse, running from September 21st to October 20th. While the event is hosted online, the grand finale will be held at the xDay conference, in Bucharest, Romania, with optional in-person attendance. The MultiversX ecosystem has rapidly grown to become a leading force in the blockchain space, boasting an impressive 2.3 million wallets, over 345 million processed transactions, and a thriving community of builders with 2,500+ tokens, 6,500+ applications and over 2 million NFTs created. About MultiversX MultiversX is a highly scalable, secure and decentralized blockchain network created to enable radically new applications, for users, businesses, society, and the new metaverse frontier. About Encode Encode Club is a leading web3 education community. Its mission is to help ambitious, talented people achieve personal and professional goals together in web3. Encode does this through organising high-quality programmes including hackathons, coding bootcamps, educational workshops, and accelerators in partnership with the leading blockchain protocols. Once participating in the programming, they help people get hired through the dedicated recruitment arm or receive investment through the investment fund. About DoraHacks DoraHacks is a global hackathon organizer and one of the world's most active developer incentive platforms. It creates a global hacker movement in blockchain, quantum computing and space tech, and provides a wide range of toolkits to help developers around the world team up and fund their ideas and BUIDLs via hackathons, bounties, grants and more. Distributed by STORM Partners. Contact Adrian Bono for interviews and quotes - adrian.bono@storm.partners or telegram @STORMPartners Contact Details Media Contact: Dan Voicu, Head of Communications dan.voicu@multiversx.com

September 22, 2023 10:49 AM Eastern Daylight Time

Image

CREATOR REJECTED BY HOLLYWOOD

Pinion Newswire

The show series tentatively titled Who’s On? was rejected by all the major networks, CBS, NBC, ABC, & FOX, as well as OTT’s Mark Burnett. Show creator Richard Sutherland remained stoic about the news that the networks wouldn’t even review his treatment. It really did not surprise him. “It takes a lot of work to break into show business these days” Sutherland says, “and there’s a lot of closed doors, but when one door closes, another one opens up.” The television series conjured by Sutherland about a manager for a rock band who dreams up a reality television series – where unknown hot shot guitar players are pitted against one another in a live performance in front of a voting audience – and tries to pitch it to the big networks might have to find a prospective buyer in a more receptive foreign country, one that also has television. Russia has one hundred and forty-four million people, and they have television, so it would be a viable country to host a show like Sutherland imagines, but there’s a problem. Russia and the United States aren’t getting along too well right now. If only Russia and the U.S. were on better terms, like in the old days, Sutherland could then take his pitch to Channel One Russia without the threat of being called a Putin puppet. To this end, Sutherland says he’s willing to act as negotiator between the U.S. and Russia in a neutral country to be determined; he’ll do anything to get his pitch in front of Russian television producers who would almost certainly be more receptive than American television networks. Russia’s invasion of Ukraine was not very nice, but then Sutherland’s also sensitive to the encroachment of NATO bases in Europe as being one of the catalysts to the Russian invasion. Both parties appear to share some responsibility, and Sutherland says he’s just the man to forge a peace treaty. In fact, Sutherland says if he can get both parties to the table, he’s pretty sure he can get a deal done in three days. Who’s On? show creator Richard Sutherland based the television series he conjured on his own life as the manager of the rock bands R.U. Serious and the SeeWhyEh. The lineup of the latter cannot be disclosed for obvious reasons, but for all intents and purposes R.U. Serious appears to be George (the Anvil) Kenney on drums, Courtney Whitney on bass, Sid Huff on vocals, and George (the Hammer) MacArthur on the electric guitar. Sutherland’s first attempt at producing a music video for the rock band The Next Machine was flop, racking up only a few hundred views in its first year, but Richard Sutherland says when one door closes, another one opens up. The first single, Wild Thing, from their forthcoming double album Are You Serious R.U. Serious has been getting a lot of attention in the music industry. The video for Wild Thing is dropping any day now. Pinkfong’s Baby Shark is the most watched video in Youtube history with thirteen billion views, but the band believes it can surpass Baby Shark’s view count with their video for Wild Thing. The band puts their odds of exceeding Baby Shark view count at two to one. Sutherland says he’s looking forward to working with both President J. Biden and Prime Minister Putin, and he’s set up a hotline to take calls from Washington and Moscow. The number Richard Sutherland can be reached at is: 705-464-1316 Email: info@generalmanagement.ca www.r-u-serious.com www.seewhyeh.com www.kingoftheblews.com Contact Details General Management Inc. Richard Sutherland +1 705-464-1316 info@generalmanagement.ca

September 22, 2023 09:45 AM Eastern Daylight Time

Image

4GLOBAL using new trial to hone AI and machine learning techniques

4GLOBAL PLC

4GLOBAL PLC (AIM:4GBL) chief development officer Utku Toprakseven speaks to Thomas Warner from Proactive London after the UK-based data, services and software company announced it is embarking on a Trial within Places Leisure to understand more about how its technology can help generate actionable insights for health and fitness operators. The partnership aims to harness artificial intelligence (AI) and machine learning to analyse participation data from the physical activity sector. The data-driven approach will enable predictive analysis to enhance business decisions, improve customer experiences, and target key business objectives like higher retention and acquisition rates. The initiative also seeks to re-energise gym members, understanding their motivations and providing tailored interventions to keep them active. While benefiting gym-goers and facility operators, this collaboration also aligns with 4GLOBAL's objective of transforming data into actionable insights. Toprakseven also hinted at future innovations, emphasising AI, machine learning, and a focus on the ESG agenda in the company's R&D efforts. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

September 22, 2023 09:23 AM Eastern Daylight Time

Video

Chesnara CEO upbeat on M&A prospects after positive first half

Chesnara PLC

Chesnara PLC (LSE:CSN) CEO Steve Murray visits the Proactive London studio to speak with Thomas Warner after the life and pensions company released its 2023 half year results. Murray gives an update on the company's interim performance, highlighting positive cash generation that will support the 19th consecutive increase in the interim dividend. The value of the firm has also been growing well, with mergers and acquisitions (M&A) playing a pivotal role alongside organic growth. He says Chesnara's solvency ratio remains robust, safeguarding the progressive dividend policy and paving the way for further M&A ventures. Murray also emphasises the success of operational deliveries, leadership transitions, and the promising M&A pipeline. "I think the fact that we have done four deals over the last two years really is a message to say that [the M&A side of] the strategy has been rejuvenated... and we're seeing further opportunities hopefully to add to the value of the group through M&A over the medium term as well." Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

September 22, 2023 09:14 AM Eastern Daylight Time

Video

Landore Resources passes "very important milestone" on journey to dual listing

Landore Resources Ltd

Landore Resources Ltd (AIM:LND) CEO Claude Lemasson speaks to Thomas Warner from Proactive after the mining exploration and development firm announced it has been approved by the TSX Venture Exchange to list ordinary shares, subject to fulfilling certain pre-conditions. Lemasson describes it a very important milestone, and says that most of the remaining conditions are "administrative in nature." He adds that one of the outstanding conditions relates to a fundraise tied to the listing and hopes to have met all the requirements by the end of October. Lemasson emphasises that floating on the TSX-V will not replace the company's London listing but add to it, and allow North American and Canadian investors easier access to the firm's shares. Post-listing, the Landore's primary focus will be on advancing the BAM Gold Project in northern Ontario. This involves a drilling campaign on the BAM deposit, leading to a revised resource estimate and a subsequent pre-feasibility study. Lemasson, who has been CEO since the summer, expresses satisfaction with the project and the team, highlighting new hires in Toronto and increased company exposure. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

September 22, 2023 09:07 AM Eastern Daylight Time

Video

Cartel Blue, Inc. Announces its Plan to Submit a Regulation A Filing

Cartel Blue, Inc.

Laguna Niguel, California – TheNewswire - iCrowdNewswire. – 22 September, 2023 – Cartel Blue, Inc. (OTC:CRTL), a Nevada corporation, and manufacturer of Hemp Cigars, and THC Products and branded accessories, reported it is preparing a Tier 1 offering under Regulation A, and will commence the sale of 250,000,000 shares of its common stock under the offering after the registration statement is declared effective by the United States Securities and Exchange Commission (the “SEC”). Cartel Blue’s Common Stock currently trades on the OTC Exchange OTC Market’s Pinks under the symbol “CRTL”. The Company manufactures and distributes hemp consumable products, including branded cigars and cigarillos, 0.3 THC (psychoactive compound delta-9-tetrahydrocannabinol) Edible Gummies, CBD oil products, vape pens and branded accessories (“products”) from its Fort Lauderdale facility. This Regulation A offering raises funds for Cartel’s business expansion needs to meet the growth in demand for its branded products, and the Company’s secured new contracts with national convenience store chains and liquor stores in Southern California during the previous two quarters. Cartel also expanded its product offerings, and began distribution through its affiliate, Distributolgov.com, including supply of 0.3 THC (psychoactive compound delta-9-tetrahydrocannabinol) products ( https://finance.yahoo.com/news/cartel-blue-inc-reports-increased-082000005.html ). Click Image To View Full Size Cartel plans to expand distribution of certain retail products, now legal in all 50 States after an 85-year ban, made possible when the 2018 Farm Bill was signed into law on December 20, 2018, which legalized industrial hemp not exceeding.03 THC dry weight federally. Reg A – Intended Use of Proceeds Cartel Blue, Inc.’s CEO, Philip Moreb, oversees daily operations, and confirmed the Company plans to use the proceeds of the Tier 1 offering to expand its manufacturing capacity for wider distribution in the U.S. market, with the build out of two (2) 10,000 Sq. Ft. hydroponic indoor grow centers located in Palm Desert, California and at its existing Fort Lauderdale, Florida location, for cultivation of high-grade organic hemp ( https://cartelscigars.com/wp-content/uploads/2022/08/updated-file-r66-new-1661309494-1661360351.pdf ). These facilities will supply hemp for manufacture of Cartel Blue’s branded products, and will also be sold to wholesalers as a secondary market. Each facility will consist of manufacturing suites, equipment, packaging, labeling equipment and distribution center. The facilities will also support extraction of CBD oil (dissolute extraction) for its CBD oil Products. The Company expects expanded facilities to produce 300,000 units of cigar products per month. Click Image To View Full Size Safe Harbor Disclaimer This press release may contain certain forward-looking statements and information, as defined within the meaning of the Private Securities Litigation Reform Act of 1995, or Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and is subject to the safe harbor created by those sections, as applicable. Such forward-looking statements include, the development, costs, and results of new business opportunities and uses words such as “plan(s)”, “intend(s)”, “anticipate(s),” “seek”, “believe”, “estimate,” “expect”, “project”, or similar phrases to summarize beliefs, plans, expectations, or intentions regarding the future, and are forward-looking in nature and subject to risks, uncertainties, and other factors, which may cause the actual results, performance, or achievements of Cartel Blue, Inc. to be materially different from the statements made herein. Actual results could differ from those projected in any forward-looking statements. Such factors include, among others, the inherent uncertainties associated with new projects, impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations, or intentions will prove to be accurate. Contact Information: Name: Cartel Blue, Inc. Email: philip@cartelscigars.com Job Title: Investor Relations

September 22, 2023 09:01 AM Eastern Daylight Time

Image

How COMPASS Pathways Is Leveraging AI To Revolutionize The Mental Healthcare Space

COMPASS Pathways

By Faith Ashmore, Benzinga Artificial Intelligence (AI) is rapidly penetrating a number of different sectors, including healthcare. The use of AI in mental health has opened up the possibility of new avenues of care, potentially allowing for more efficient diagnosis, treatment and patient care. Machine learning algorithms can analyze vast amounts of data – including patient medical records, genetic information and environmental factors – to potentially identify patterns and predict disorders. Clinicians can also benefit from more accurate and timely diagnoses based on objective digital signals. COMPASS Pathways (NASDAQ: CMPS) is currently developing AI-informed digital systems to assist an investigational treatment for mental health conditions, including treatment-resistant depression (TRD), anorexia nervosa and post–traumatic stress disorder (PTSD). The company is best known for its investigational psilocybin treatment and its R&D focus on mental health conditions. Its goal is to develop new and more effective treatment options for individuals with treatment-resistant depression and other difficult-to-treat mental health conditions. The company’s innovative approach has already yielded promising results, and they received FDA Breakthrough Therapy designation in the U.S. and Innovative Licensing and Access Pathway designation in the U.K. for their investigational COMP360 psilocybin treatment. In late 2021, COMPASS Pathways announced the completion of a randomized, controlled double-blind phase 2b study of COMP360 psilocybin treatment involving 233 patients with TRD in 22 sites across Europe and North America. However, the company believes that drug innovation alone is not enough to improve mental health care. In addition to COMP360 and to better support the drug, COMPASS Pathways has developed three digital tools to help support patients and therapists to ensure the best possible treatment. While these tools will be used in tandem with the COMP360 treatment, the tools were built to be scalable and revolutionize the treatment of mental health disorders. Therapist COMPanion is a web-based portal that supports therapists through all phases of patient care. Psilocybin administration is relatively new to providers so Therapist COMPanion acts as a tool for the provider to ensure that treatment is conducted in the right way. myPathfinder is a patient-facing app that provides guidance throughout COMP360. The psilocybin treatment is grouped into three phases: preparation, administration and integration. COMPASS Pathways was built on the belief that patients deserve better care, especially patients who have been underserved and felt overlooked by the system after being diagnosed as treatment-resistant. This platform is an essential component of taking better care of the patient and ensuring they have the tools to understand their treatment and psilocybin experience. However, the company’s most expansive digital tool is Chanterelle, an AI and analytics infrastructure that can be used for continuous optimization throughout treatment, as well as data collection to help expand a deeper understanding of treatment-resistant disorders. The program records sessions with the patients, with their consent, and can glean a better understanding of success rates using AI and natural language processing. Chanterelle uses the BART large language model which denotes the valence and arousal of the participant and therapist to assess the emotional tenor of the conversation and to better understand if treatment is succeeding. Chanterelle’s application could go beyond COMP360 and was designed to be scalable. The company is working to provide a more concrete and evidence-based way of measuring the success of treatment. While COMPASS Pathways is not the only mental healthcare company to bridge the gap between AI and care, the company’s ability to design platforms that can be used for a variety of disorders sets it apart from competitors like MindMed and Medtronic. Featured photo by Steve Johnson on Unsplash Company BioCOMPASS Pathways plc (Nasdaq: CMPS) is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. We are pioneering the development of a new model of psilocybin therapy, in which our proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support. COMP360 has been designated a Breakthrough Therapy by the U.S. Food and Drug Administration (FDA) and has received Innovative Licensing and Access Pathway (ILAP) designation in the UK for treatment-resistant depression (TRD). We have commenced a phase 3 clinical program of COMP 360 psilocybin therapy in TRD, the largest randomised, controlled, double-blind psilocybin therapy clinical program ever conducted. Previously, we completed a phase 2b study with top line data showing a statistically significant (p<0.001) and clinically relevant improvement in depressive symptom severity after three weeks for patients who received a single high dose of COMP360 psilocybin with psychological support. We are also conducting phase 2 clinical studies of COMP360 psilocybin therapy for post-traumatic stress disorder (PTSD) and anorexia nervosa. COMPASS is headquartered in London, UK, with offices in New York and San Francisco in the United States. Our vision is a world of mental wellbeing. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Stephen Schultz stephen.schultz@compasspathways.com

September 22, 2023 08:30 AM Eastern Daylight Time

News Release

Tech Meets Classic Art: How This New Platform Can Propel You to Wealth?

RoundHouse Media

The convergence of technology and art, two seemingly disparate realms, sparks curiosity and excitement. Domini.art ($DOMI) is at the forefront of this fusion, a groundbreaking platform that dares to merge classic art with cutting-edge technology. As investors seek diverse opportunities for wealth creation, one question resonates: Can $DOMI be the gateway to wealth through art and technology? Domini.art takes the timeless beauty and cultural significance of blue-chip art and integrates it with the transparency, accessibility, and security offered by blockchain technology. This harmonious blend promises to reshape the landscape of art ownership and investment. The platform uses trending NFTs (non-fungible tokens) to achieve its goal of fractionalizing ownership. This article delves into Domini.art, exploring its potential for wealth creation and shedding light on why it has captured the imagination of investors with interests in art and technology. Domini.art ($DOMI): Your Pathway to Prosperity via Blue Chip Artworks Domini.art, a cutting-edge blockchain platform, is making waves by merging the timeless beauty of classic art with innovative technology. This harmonious convergence promises a unique gateway to potential wealth. As its prominence grows in the crypto market, Domini.art presents itself as a top crypto investment, piquing the interest of art connoisseurs and savvy investors seeking immense returns. At its core, the blockchain ICO represents a bridge between tradition and progress. It leverages the power of blockchain technology to transform classic artworks into unique and tradable assets. By fractionalizing ownership, Domini.art opens the doors to a broader audience, allowing them to invest in prestigious artworks they might have only dreamed of owning. This democratization of art ownership is one of Domini's standout features, breaking down barriers and granting accessibility like never before. The integration of trending NFTs into investments sets Domini.art apart. These digital certificates of authenticity and ownership provide unmatched transparency and security in the art market. With Domini.art, every brushstroke and detail of a masterpiece can be traced and verified on the blockchain, ensuring the artwork's integrity and the investor's peace of mind. This feature, amongst others, makes Domini.art a reasonable consideration for those seeking a top crypto investment for long-term returns. The platform's liquidity, flexibility, and promise of diversified art portfolios make it attractive for blockchain-based assets. With a total supply of 1 billion $DOMI tokens, the project is carefully managed to ensure its rise on the initial coin offering list. 650 million tokens are allocated to a growing presale phase, and the project offers a vesting period spanning 12 weeks. Domini.art has implemented strategies to maintain token value and stability. The initial DeFi coin price of $0.0021 and an approximate launch price of $0.00924 hint at the potential for value appreciation. Its commitment to expert guidance and secure storage solutions for traditional art reinforces Domini.art as a reliable and innovative platform. The blockchain ICO implements a deflationary token burn with a 2% tax and token redistribution with a 3% tax, further contributing to the platform's unique tokenomics, which may provide opportunities for investors. The project is in its first presale stage, selling each $DOMI token at a DeFi coin price of $0.002625. So far, about 37 million tokens have been sold. With less than 60% of the allocated tokens for this stage left, now is the best time to invest in Domini.art before the price rises to $0.00294 in the next presale stage. Conclusion Domini.art seamlessly blends classical art with cutting-edge technology, offering a unique gateway to potential wealth. With features like fractional ownership, liquidity, and NFT integration, Domini.art presents an alluring landscape as it scales the initial coin offering (ICO) list. It beckons investors to explore the convergence of art and technology, inviting them to embark on a journey where tradition meets innovation. As the digital age continues to reshape industries, Domini.art stands at the forefront, potentially propelling individuals towards newfound wealth and unique investment opportunities. Learn more about $DOMI here: Visit Domini Presale | Join Our Community Keywords: Domini.art, $DOMI, trending NFTs, top cryptocurrency investment, initial coin offering list, DeFi coin price, blockchain ICO Contact Details James Knight marketing@domini.art Company Website https://domini.art

September 22, 2023 08:00 AM Eastern Daylight Time

1 2 3 4 5 ... 2811